Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adial, Catalyst Biosciences, Compugen, Elios, Freeline, Immunicum, Ocular Therapeutix, Soricimed, Zogenix.

Biopharmas raising money in public or private financings, including: Adma, AGTC, Dare, Inventiva, Miragen, Orphazyme, Phio, Rapt, Salarius, Tonix.

Quarterly snapshots from biopharma companies with marketed products, including: Seattle Genetics.

New hires and promotions in the biopharma industry, including: Biomotiv, Complexa, DBV, Frequency, Immunomolecular, Nymox, Plus, Trillium, Vectivbio.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aria CV, Atlantic Therapeutics, In2bones, Life Spine.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bgi, Bioventrix, Curetis, Fibroline, Gatt Technologies, MGI Tech, Nano-X Imaging, Quaphaco, Smith & Nephew, USArad Holdings.

Med-tech firms raising money in public or private financings, including: Connectyx Technologies, Lunaphore Technologies, Pentixapharm, Rewalk Robotics.

New hires and promotions in the med-tech industry, including: Angiodynamics, Apertiva, Procept Biorobotics, Sonendo, Syntactx.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aquestive, Blueprint, Chiesi, Kleo, Neurosense, Novan, Protalix, Realta, Revance.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atreca, Aurigene, Chiesi, Curis, Evgen, Foamix, Generex, Genprex, Janone, Jounce, Marinomed, Menlo Therapeutics, Merck, Nanostring, Oncternal, Scholar Rock, Summit.